4Life transfer factor cardio Receives New Patent
4Life Research™ announced today that the United States Patent & Trademark Office (USPTO) has awarded the company a composition patent that protects the 4Life Transfer Factor Cardio formula until 2025. This is the company's sixth worldwide patent. 4Life has numerous international patents and dozens of patent applications pending.
4Life’s progressive science and pursuit of patent protection strengthens the business opportunity for 4Life distributors with the exclusive right to market 4Life Transfer Factor® products. 4Life President Steve Tew: “We invest a great deal of resources into patent protection on behalf of our distributors because we know that the opportunity they share must accompany the kind of exclusivity, credibility, and longevity that patents exist to provide.”
4Life's commitment to patents includes an emphasis on research and development to generate formulas, compositions, and processes that are patentable. While 4Life's legal team concentrates on patent acquisition, the International Product Registration department focuses on registrations around the world to support distributor growth now and in the future. In 2010, 4Life completed 101 product registrations in 30 countries.
4Life Founder and CEO David Lisonbee: "Patent protection is just one way that we work to empower 4Life distributors with exclusivity and credibility in the marketplace. 4Life patents provide our distributors with security for decades to come.
4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.
